Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer

被引:41
作者
Fishman, A
Klein, A
Zemer, R
Zimlichman, S
Bernheim, J
Cohen, I
Altaras, MM [1 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Meir Hosp, Sapir Med Ctr,Gynecol Oncol Unit, IL-44281 Kfar Saba, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Meir Hosp, Sapir Med Ctr,Mol Biol Lab, IL-44281 Kfar Saba, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Meir Hosp, Sapir Med Ctr,Pathol Lab, IL-44281 Kfar Saba, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Meir Hosp, Sapir Med Ctr,Dept Obstet & Gynecol, IL-44281 Kfar Saba, Israel
关键词
lymph nodes; endometrial cancer; cytokeratin-20; reverse transcription polymerase chain reaction;
D O I
10.1006/gyno.2000.5781
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Cytokeratins are constituents of the intermediate filaments (IFs) of epithelial cells which are expressed in various combinations, depending on the type of epithelium and degree of differentiation. We have reported (R. Zemer, A. Fishman, J. Bernheim, S. Zimlichman, O. Markowitz, M. Altaras, and A. Klein, Gynecol Oncol 70:410-413, 1998) on the determination of cytokeratin-20 (CK-20) by reverse transcription polymerase chain reaction (RT-PCR) in the detection of endometrial cancer cells as a potential biomarker. In that study, we also found that by using immunocytochemistry, most carcinomas were found to be negative for CK-20. The sensitivity and specificity rates obtained by using the RT-PCR method were 94.4 and 91%, respectively. Objective. The aim of this study is to investigate the feasibility and potential of the specific mRNA marker, CK-20, to detect endometrial cancer cells-micrometastases (MMs)-by RT-PCR in lymph node (LN) samplings of patients undergoing hysterectomy for endometrial carcinoma. Method. We used the RT-PCR method to determine the expression of CK-20 in the LNs of 20 patients [study group (SG)] who were being surgically staged and treated for endometrial carcinoma. The specificity of the mRNA CK-20 marker was examined in LNs obtained from five healthy patients [control group (CG)] who underwent abdominal hysterectomy and bilateral salpingooopherectomy for benign gynecologic conditions. The LNs obtained from the SG and CC patients were prepared together before mRNA extraction. RNA of the various cell pellets was extracted and RT-PCR was performed with CK-20 primers. RT-PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining against PCR size markers. Specificity of the RT-PCR products was examined by Southern blotting. Results. Histopathologic examinations demonstrated the presence of metastases in two (10%) SG patients. These patients were also CK-20 positive. Of the remaining 18 patients with negative histopathologic results, 6 (33%) were CK-20 positive and 12 (67%) were negative. All the CG patients were CK-20 negative (specificity, 100%). Conclusions. The results obtained in this study suggest that RT-PCR of CK-20 is more sensitive than traditional histopathologic methods in the diagnosis of MMs in LNs of patients with endometrial cancer, Thus, due to the aforementioned characteristics of CK-20, it may be considered a powerful biomarker in the detection of MMs in LNs of patients with endometrial cancer. (C) 2000 Academic Press.
引用
收藏
页码:399 / 404
页数:6
相关论文
共 29 条
  • [1] *AM CANC SOC, 1997, CANC FACTS FIG 1997
  • [2] Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma
    Bell, JG
    Minnick, A
    Reid, GC
    Judis, J
    Brownell, M
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 66 (03) : 388 - 392
  • [3] Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
    Bostick, PJ
    Chatterjee, S
    Chi, DD
    Huynh, KT
    Giuliano, AE
    Cote, R
    Hoon, DSB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2632 - 2640
  • [4] DETECTION OF EPITHELIAL CANCER-CELLS IN PERIPHERAL-BLOOD BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION
    BURCHILL, SA
    BRADBURY, MF
    PITTMAN, K
    SOUTHGATE, J
    SMITH, B
    SELBY, P
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 278 - 281
  • [5] COOPER D, 1985, LAB INVEST, V52, P243
  • [6] Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing High-dose chemotherapy and autologous bone marrow transplantation
    Fields, KK
    Elfenbein, GJ
    Trudeau, WL
    Perkins, JB
    Janssen, WE
    Moscinski, LC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) : 1868 - 1876
  • [7] Futamura M, 1998, J SURG ONCOL, V68, P34, DOI 10.1002/(SICI)1096-9098(199805)68:1<34::AID-JSO8>3.0.CO
  • [8] 2-M
  • [9] GOLDHIRSCH A, 1990, LANCET, V335, P1565
  • [10] Gunn J, 1996, LAB INVEST, V75, P611